Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Clinigen CFO to depart, replacement search underway

Wed, 25th Aug 2021 20:39

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and not separately reported by Alliance News:

----------

Clinigen Group PLC - Staffordshire-based pharmaceuticals and services provider - Says Nick Keher stepping down as a director with immediate effect, and as chief financial officer following a handover, to "pursue other business interests". Richard Paling, Clinigen's financial controller since April 2017, will assume the role of interim CFO. External search for a new, permanent CFO is underway, company says.

----------

Edenville Energy PLC - operates the Rukwa coal project in Tanzania - Appoints Franco Caselli as a non-executive director, effective immediately. He has more than 40 years of experience in the energy sector. He founded Terracon Resources Srl, which was involved in energy and mining projects in south Europe and Africa. "We look forward to benefitting from his skills, advice and guidance, particularly as we review additional opportunities following our recapitalisation earlier this year," says Non-Executive Chair Jeff Malaihollo.

----------

Polar Capital Technology Trust PLC - technology-focused investment trust - Appoints two new independent non-executive directors. First is Jane Pearce, who is currently a non-executive director at Shires Income PLC and has a "strong and recent understanding" of corporate governance and current accounting standards. The other hire is Catherine Cripps, currently a non-executive director of Goldman Sachs International, Goldman Sachs International Bank and the Nuclear Liabilities Fund Ltd. Both join Polar Capital Technology on September 6.

----------

Aquis Exchange PLC - London-based operator of Aquis Stock Exchange - Appoints Daniel Lopez to the board of its subsidiary, Aquis Stock Exchange, as a non-executive director. Appointment receives approval from the UK Financial Conduct Authority. "Danny brings a deep knowledge of next-generation technology to AQSE, with significant experience across financial services and cyber security technology," firm says. He is chief executive of Glasswall, a cyber security company, as well as a non-executive director of Innovate Finance, an independent industry body that "champions the global FinTech community" in the UK.

----------

Greatland Gold PLC - Havieron gold and copper project in Western Australia - Says Paul Hallam to join board as a non-executive director. "Paul is a senior mining industry professional with more than 40 years of Australian and international resource experience across a range of commodities including both surface and underground mining," it says. He appointment is effective Wednesday next week.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
14 Jul 2020 09:07

Clinigen FY revenues continue to rise, profit growth slowed by Covid-19

(Sharecast News) - Pharmaceutical group Clinigen warned full-year profit growth would be at the lower end of guidance as a result of the Covid-19 pandemic and the launch of a low-cost competitor to its Foscavir drug.

Read more
13 Jul 2020 16:29

Clinigen gets orphan drug designation for 'aldesleukin' in the US

(Sharecast News) - Pharmaceutical services company Clinigen Group announced on Monday that the US Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has granted orphan drug designation for 'aldesleukin', in the treatment of amyotrophic lateral sclerosis (ALS).

Read more
13 Jul 2020 13:48

Monday broker round-up

(Sharecast News) - Kingfisher: RBC Capital Markets reiterates outperform with a target price of 275.0p

Read more
13 Jul 2020 08:41

Clinigen Gets US Orphan Drug Designation For ALS Treatment Aldesleukin

Clinigen Gets US Orphan Drug Designation For ALS Treatment Aldesleukin

Read more
14 Jun 2020 19:22

Sunday newspaper round-up: Two meters, Rolls Royce, Clinigen

(Sharecast News) - Senior scientists have reported flaws in an influential World Health Organization-commissioned study into the risks of coronavirus infection and say it should not be used as evidence for relaxing the UK's 2-metre physical distancing rule. Critics of the distancing advice, which states that people should keep at least 2 metres apart, believe it is too cautious. They seized on the research commissioned by the WHO, which suggested a reduction from 2 metres to 1 would raise infection risk only marginally, from 1.3% to 2.6%. - Guardian

Read more
28 May 2020 13:34

Thursday broker round-up

(Sharecast News) - Provident Financial: RBC Capital Markets reiterates sector performer with a target price of 195p.

Read more
28 May 2020 09:37

UK BROKER RATINGS SUMMARY: Jefferies Initiates Greggs, Games Workshop

UK BROKER RATINGS SUMMARY: Jefferies Initiates Greggs, Games Workshop

Read more
26 May 2020 17:50

Clinigen Chair Leaves Audit Committee After Shareholder Engagement

Clinigen Chair Leaves Audit Committee After Shareholder Engagement

Read more
12 May 2020 10:37

McCarthy & Stone CFO Rowan Baker Defects To Laing O'Rourke

McCarthy & Stone CFO Rowan Baker Defects To Laing O'Rourke

Read more
16 Apr 2020 12:00

Clinigen Says Annual Trading In Line; Signs Erwinase License Agreement

Clinigen Says Annual Trading In Line; Signs Erwinase License Agreement

Read more
24 Mar 2020 16:00

DIRECTOR DEALINGS SUMMARY: Pearson And IHG Chairs Buy Amid Virus Pain

DIRECTOR DEALINGS SUMMARY: Pearson And IHG Chairs Buy Amid Virus Pain

Read more
20 Mar 2020 09:49

UK BROKER RATINGS SUMMARY: BHP Gets Upgrades From JPMorgan, Deutsche

UK BROKER RATINGS SUMMARY: BHP Gets Upgrades From JPMorgan, Deutsche

Read more
18 Mar 2020 13:42

Wednesday broker round-up

(Sharecast News) - Polypipe: Deutsche Bank upgrades to buy with a target price of 550p.

Read more
12 Mar 2020 16:05

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
11 Mar 2020 13:37

Wednesday broker round-up

(Sharecast News) - Clinigen Group: Liberum upgrades to buy with a target price of 780.0p.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.